Novartis launches COPD inhalers in China

Novartis launches COPD inhalers in China

Source: 
Drug Delivery Business News
snippet: 

Novartis (NYSE:NVS) has launched its Ultibro Breezhaler and Seebri Breezhaler in China for the treatment of chronic obstructive pulmonary disease.